Barclays
NGVT icon

Barclays’s Ingevity NGVT Stock Holding History

Barclays’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-192
Closed -$9K – 6751
2016
Q3 		$9K Sell
192
-448
-70% -$18.9K ﹤0.01% 5833
2016
Q2 		$22K Buy
+640
New +$20K ﹤0.01% 5228

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Barclays's NGVT Position: Q1 2026 in Review

Barclays reduced its Ingevity (NGVT) stake by 84% in Q1 2026, selling an estimated $3.41M and leaving 9,224 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Barclays first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $6.54M in Q3 2018. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Barclays held 9,224 shares of Ingevity worth $657K as of Q1 2026.
  • Barclays sold 49,881 Ingevity shares in Q1 2026, an estimated $3.41M.
  • Ingevity made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3016 holding.
  • Barclays first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Barclays's Ingevity position peaked at $6.54M in Q3 2018.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.